IQVIA Holdings is the world's largest provider of biopharmaceutical development services and commercial outsourcing services. The company manages the largest contract research organization (CRO) in the world, with a focus on Phase II, III, and IV clinical trials and related analysis. It also provides contract sales representation, consulting research, and other healthcare services. The Durham, North Carolina-based company was founded in 1982 and went public in May 2013. In October 2016, Quintiles merged with IMS, a pharmaceutical data provider; a little over a year later it took the new name IQVIA. The merger has enabled it to integrate historical data
ALLE
TFX
IT
AME
WST
Jasper Hellweg
Associate Analyst: Growth Pharmaceutical, Medical Technology & Financial Technology